Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthew Ralstin"'
Autor:
Bryan Holcomb, Christopher Sweeney, Michele T. Yip-Schneider, Huangbing Wu, Matthew Ralstin, Sundar Neelakantan, Peter A. Crooks, C. Max Schmidt, Victor Njoku
Publikováno v:
Pancreas. 37:e45-e53
Objectives: Cancer of the exocrine pancreas is the fourth leading cause of cancer-related deaths in the United States. The efficacy of a novel bioavailable anticancer agent, dimethylamino-parthenolide (DMAPT), and the cyclooxygenase 2 inhibitor, cele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e00f97d84691d7cd4dee40b279dff04
https://doi.org/10.1097/mpa.0b013e318172b4dd
https://doi.org/10.1097/mpa.0b013e318172b4dd
Autor:
Sundar Neelakantan, Christopher Sweeney, Matthew Ralstin, Harikrishna Nakshatri, Peter A. Crooks, Reid C. Vegeler, Michele T. Yip-Schneider, Huangbing Wu, C. Max Schmidt
Publikováno v:
Journal of Surgical Research. 143:169-176
Lung cancer is the leading cause of cancer deaths in the United States. Inflammatory molecules, cyclooxygenase-2 (COX-2) and nuclear factor kappa B (NF-kappaB) have been implicated in lung carcinogenesis. The therapeutic potential of celecoxib, a COX
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f10df329be652a0936fe16e9854d17c
https://doi.org/10.1016/j.jss.2007.08.007
https://doi.org/10.1016/j.jss.2007.08.007
Autor:
Constantin T. Yiannoutsos, C. Max Schmidt, Peter A. Crooks, Sundar Neelakantan, Matthew Ralstin, Christopher Sweeney, Harikrishna Nakshatri, Michele T. Yip-Schneider, Huangbing Wu, Stephen Noble
Publikováno v:
Molecular Cancer Therapeutics. 6:1736-1744
The design of novel targeted or combination therapies may improve treatment options for pancreatic cancer. Two targets of recent interest are nuclear factor-κB (NF-κB) and cyclooxygenase (COX), known to be activated or overexpressed, respectively,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a85ed9abe13b29ee7e31825a26c77066
https://doi.org/10.1158/1535-7163.mct-06-0794
https://doi.org/10.1158/1535-7163.mct-06-0794
Autor:
Brent Siesky, Hanna J. Garzozi, Carlos Rospigliosi, Itay Ben Zion, L. Jay Katz, Alon Harris, Matthew Ralstin, Adam Werne, L. McCranor, Danny Moore, William N. Steinmann
Publikováno v:
Journal of glaucoma. 18(4)
PURPOSE To determine the interobserver reproducibility of Heidelberg retinal flowmeter (HRF) blood flow measurements using independently selected study areas for pixel-by-pixel analysis. PATIENTS AND METHODS Blood flow measurements were performed on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::662a88a4c880c7f6b51340a927142765
https://pubmed.ncbi.nlm.nih.gov/19365191
https://pubmed.ncbi.nlm.nih.gov/19365191
Autor:
Matthew Ralstin, Patrick J. Klein, Earl A. Gage, Eric A. Wiebke, C. Max Schmidt, Michele T. Yip-Schneider
Publikováno v:
Molecular cancer research : MCR. 4(6)
Chemotherapy to date has not been effective in the treatment of human hepatocellular carcinoma. More effective treatment strategies may involve combinations of agents with activity against hepatocellular carcinoma. Parthenolide, a nuclear factor-κB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5e7628ce0f8da7805c149cdad7bbd6
https://pubmed.ncbi.nlm.nih.gov/16778086
https://pubmed.ncbi.nlm.nih.gov/16778086
Autor:
Christopher Sweeney, Constantin T. Yiannoutsos, Michele T. Yip-Schneider, Harikrishna Nakshatri, Matthew Ralstin, Christian M. Schmidt, Peter A. Crooks, Stephen Noble, Huangbing Wu, Sundar Neelakantan
Publikováno v:
Molecular Cancer Therapeutics. 6:2816-2816
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6def2db97429a2a6c16eba8b00572f34
https://doi.org/10.1158/1535-7163.mct-06-10-cor
https://doi.org/10.1158/1535-7163.mct-06-10-cor